Your browser doesn't support javascript.
Response to: Note the distinction between myocarditis, novel coronavirus myocarditis and COVID-19 vaccine-associated myocarditis.
Awaya, T; Koizumi, T; Enomoto, Y; Moroi, M; Nakamura, M.
  • Awaya T; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Koizumi T; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Enomoto Y; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Moroi M; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Nakamura M; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
QJM ; 115(10): 696, 2022 10 25.
Article in English | MEDLINE | ID: covidwho-2087828

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Qjmed

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Qjmed